Guggenheim CurrencyShares® Exchange Traded Products

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Guggenheim CurrencyShares® Exchange Traded Products Declare Monthly Distributions

NEW YORK, Dec. 01, 2016 (GLOBE NEWSWIRE) -- Guggenheim Investments, the investment management division of Guggenheim Partners, today announced the distribution declarations for CurrencyShares ® Australian Dollar Trust (NYSE: FXA ).

NYSE Ticker   Fund Name Declaration Date               Ex- dividend Date           Record Date           Payable Date/Share    Distribution 
FXA   CurrencyShares Australian Dollar Trust   11.30.2016 12.1.2016 12.5.2016 12.8.2016 $ 0.04641  
                 

Distributions are made to shareholders on a pro-rata basis (in accordance with the number of shares that are owned) only in the event that the interest earned by the Trust exceeds the sum of the sponsor’s fee for the prior month plus other Trust expenses, if any. There is no guarantee that distributions will be made on a monthly basis.

CurrencyShares ® offer investors and institutions a convenient and cost-effective method of gaining investment benefits similar to that of holding foreign currencies, including potential diversification and hedging benefits. More details about the products are available at www.currencyshares.com .

About Guggenheim Investments

Guggenheim Investments is the global asset management and investment advisory division of Guggenheim Partners, with $204 billion 1 in total assets across fixed income, equity, and alternative strategies. We focus on the return and risk needs of insurance companies, corporate and public pension funds, sovereign wealth funds, endowments and foundations, consultants, wealth managers, and high-net-worth investors. Our 275+ investment professionals perform rigorous research to understand market trends and identify undervalued opportunities in areas that are often complex and underfollowed. This approach to investment management has enabled us to deliver innovative strategies providing diversification opportunities and attractive long-term results.

Diversification neither assures a profit nor eliminates the risk of experiencing investment losses.

CurrencyShares are subject to risks similar to those of stocks and may not be suitable for all investors. The value of the shares of each CurrencyShares Trust relates directly to the value of the foreign currency held by the particular Trust. This creates a concentration risk associated with fluctuations in the price of the applicable foreign currency. Accordingly, a decline in the price of that currency will have an adverse effect on the value of the shares of the particular CurrencyShares Trust. Factors that may have the effect of causing a decline in the price of a foreign currency include national debt levels and trade deficits, domestic and foreign interest rates, investment and trading activities of institutions and global or regional political, economic or financial events and situations. Investors should consider the investment objectives, risks, charges and expenses of these products carefully before investing. The prospectus pertaining to each product contains this and other information about the product. Please read the applicable prospectus, including the Risk Factors section, carefully before you invest. Shares can be bought and sold through a broker and the purchasers or sellers may have to pay brokerage commissions in connection with the transaction. Investment returns and principal value will fluctuate so that shares may be worth more or less than original cost. Shares may only be redeemed directly from the Trust by Authorized Participants via baskets (as defined in the prospectus). There can be no assurance that an active trading market for the shares will develop or be maintained. The CurrencyShares Trusts are not investment companies registered under the Investment Company Act of 1940. As a result the Trust(s) are not subject to the regulatory requirements of investment companies.

The CurrencyShares® Australian Dollar Trust , CurrencyShares® British Pound Sterling Trust , CurrencyShares® Canadian Dollar Trust , CurrencyShares® Chinese Renminbi Trust , CurrencyShares® Euro Trust , CurrencyShares® Japanese Yen Trust , CurrencyShares® Singapore Dollar Trust ,   CurrencyShares® Swiss Franc Trust and CurrencyShares® Swedish Krona Trust (each a “Trust” and collectively, the “Trusts”) has filed a registration statement (including a prospectus) with the SEC for the offerings to which this communication relates. Before you invest in the shares of a Trust, you should read the prospectus in the registration statement and other documents the Trust has filed with the SEC for more complete information about the Trust and its offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov . Alternatively, you may click the links above or the Trust will arrange to send you its prospectus if you request it by calling toll-free 800.820.0888.

The CurrencyShares Trusts are distributed by Guggenheim Funds Distributors, LLC. Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC (“Guggenheim”), which includes Security Investors, LLC (“SI”). Guggenheim Specialized Products, LLC (“GSP”), the Sponsor for the CurrencyShares Trusts, is a wholly owned subsidiary of SI. Guggenheim Funds Distributors, LLC, is affiliated with Guggenheim, SI and GSP.

Not FDIC Insured – No Bank Guarantee –May Lose Value.

TEMP 24359

1 Guggenheim Investments total asset figure is as of 09.30.2016. The assets include leverage of $10.7bn for assets under management and $0.5bn for assets for which we provide administrative services. Guggenheim Investments represents the following affiliated investment management businesses: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Real Estate, LLC, GS GAMMA Advisors, LLC, Guggenheim Partners Europe Limited and Guggenheim Partners India Management.

Media Contacts Guggenheim Ivy McLemore 212.518.9859 Ivy.mclemore@guggenheimpartners.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 144

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 263

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 159

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 242

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 327

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Franklin Universal Trust Distributions Explained: A Deep Dive

Updated Category News Views 225

Understanding Franklin Universal Trust's Distribution Sources In the investment landscape, knowing the sources of distributions can significantly inform investors about the health of their investments. Franklin Universal Trust (NYSE: FT) recently provided an update on its distribution sources, which is vital for shareholders seeking to gauge the Fund’s performance....

Continue Reading
Bitcoin Flat, Ethereum Up: Is This Your Accumulation Moment?

Updated Category News Views 149

Bitcoin's been stuck in neutral territory lately, trading flat as of Monday with a mild dip in volatility due to holiday-driven thin liquidity. It pushed up to $70,060 but faced serious resistance, retreating back into the $68,000 zone where it seems to be camping out. Volume? Yeah, that dropped a cool 17% from yesterday's action—so you know how traders get restless...

Continue Reading
Automotive Wiper Blade Market Set for Robust Expansion

Updated Category News Views 121

Anticipated Growth in the Automotive Wiper Blade Market The global automotive wiper blade market is poised for significant growth in the coming years. Projections estimate that the market value will climb to USD 11.5 billion by 2034, up from USD 6 billion in 2024. This increase signifies a compound annual growth rate (CAGR) of 6.8%. Key drivers of this growth include...

Continue Reading
Celebrated Financial Advisor Joins Ameriprise, Enhancing Services

Updated Category News Views 190

Gary Presslaff Joins Ameriprise Financial Team In a significant move for the financial services landscape, mentor Gary Presslaff has officially joined the ranks of Ameriprise Financial, Inc. (NYSE: AMP). With four decades of industry experience, Presslaff brings a wealth of knowledge and expertise, bolstering the team at Monumental Financial Planning located in Washington...

Continue Reading
Royal Mint Celebrates Iconic Metal Band with Special Coin

Updated Category News Views 237

Royal Mint Commemorative Coin for Iron Maiden's 50th Anniversary The Royal Mint has recently unveiled an impressive commemorative coin that celebrates the remarkable 50-year journey of the legendary heavy metal band, Iron Maiden. This special release is part of The Royal Mint's Music Legends series, which has previously honored iconic musicians such as Queen, Elton John,...

Continue Reading